Investigating how certain B cells help produce antibodies against viruses
IL-27-producing B cells in the antibody response
This study is looking at a special type of immune cell that helps your body fight off viruses, like the coronavirus, by producing a helpful molecule called IL-27, and it aims to find ways to make vaccines and treatments even better for people by boosting their antibody responses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11002688 on NIH RePORTER |
What this research studies
This research focuses on a specific type of B cell that produces a molecule called IL-27, which plays a crucial role in the body's immune response to viral infections. The study aims to understand how these IL-27-producing B cells enhance the production and effectiveness of antibodies, particularly in response to viral infections like the novel coronavirus. By examining the cellular mechanisms and interactions involved, the research seeks to identify ways to improve antibody responses, which could lead to better vaccines and treatments. Patients may benefit from insights gained about how to boost their immune responses against infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced viral infections or are at risk of such infections, particularly those related to the novel coronavirus.
Not a fit: Patients with autoimmune disorders or those who do not have a functional immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine strategies and treatments for viral infections, enhancing patient immunity.
How similar studies have performed: Other research has shown promising results in understanding the role of B cells in antibody responses, indicating that this approach has potential for success.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Xu, Zhenming — University of Texas Hlth Science Center
- Study coordinator: Xu, Zhenming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.